CMOs to Strengthen on Biopharma's Cytotoxic Demand, Report says
Cytotoxics will be a key growth opportunity for third-party manufacturers as biopharma increases its injectables outsourcing over the next few years, an industry report has predicted.
Archives for September 12, 2013
Roche Licenses Inovio Vaccines, Delivery Tech in $412M Deal
Roche has agreed to research, develop and commercialize Inovio Pharmaceuticals' vaccine delivery tech as well as its multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B.
US Flu Vaccine Manufacturers: Not Enough Quadrivalent Vax Supply
The US FDA approval of the new quadrivalent flu vaccine in June has not quite given manufacturers enough time to meet demand expectations, as production time can take up to about six months.
Sonoco Launches New 'Shippers' to Ensure Cold Chain
New European GDP guidance has led Sonoco to launch a series of shippers to store and transport biopharmaceuticals whilst ensuring an unbroken cold chain.
Eppendorf Gets US Patent for ‘Unopenable’ Bioreactor
Eppendorf claims its new bioreactor design overcomes the contamination risk associated with more easily opened systems.